Current topics and controversies in menstrual migraine

Headache

Volumn 52, Issue SUPPL. 1, 2012, Pages 8-11

  Calhoun, Anne H ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

estrogen; hormonal contraceptive; menstrual migraine; oral contraceptive; prevention

Indexed keywords

CONJUGATED ESTROGEN; DROSPIRENONE PLUS ETHINYLESTRADIOL; ETHINYLESTRADIOL; MESTRANOL PLUS NORETYNODREL; ORAL CONTRACEPTIVE AGENT;

BRAIN ISCHEMIA; CLINICAL PROTOCOL; CONFERENCE PAPER; ENDOMETRIOSIS; HORMONAL THERAPY; HUMAN; MENSTRUAL CYCLE; MENSTRUAL MIGRAINE; MIGRAINE; OVARY CANCER; PRIORITY JOURNAL; PROPHYLAXIS; RISK BENEFIT ANALYSIS;

FEMALE; HUMANS; MENSTRUATION; MIGRAINE DISORDERS; PREMENSTRUAL SYNDROME;

EID: 84860830762     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2012.02130.x     Document Type: Conference Paper

References (25)

1. Pinkerman B, Holroyd K,. Menstrual and nonmenstrual migraines differ in women with menstrually-related migraine. Cephalalgia. 2010; 30: 1187-1194.
2. Couturier EG, Bomhof MA, Neven AK, van Duijn NP,. Menstrual migraine in a representative Dutch population sample: Prevalence, disability and treatment. Cephalalgia. 2003; 23: 302-308. (Pubitemid 36577949)
3. MacGregor EA, Victor TW, Hu X, et al,. Characteristics of menstrual vs nonmenstrual migraine: A post hoc, within-woman analysis of the usual-care phase of a nonrandomized menstrual migraine clinical trial. Headache. 2010; 50: 528-538.
4. Calhoun AH,. A novel specific prophylaxis for menstrual-associated migraine. South Med J. 2004; 97: 819-822. (Pubitemid 39249655)
5. Sulak P, Willis S, Kuehl T, Coffee A, Clark J,. Headaches and oral contraceptives: Impact of eliminating the standard 7-day placebo interval. Headache. 2007; 47: 27-37. (Pubitemid 46096054)
6. Calhoun A, Ford S,. Elimination of menstrual-related migraine beneficially impacts chronification and medication overuse. Headache. 2008; 48: 1186-1193.
7. Mosher WD, Jones J,. Use of contraception in the United States: 1982-2008. Vital Health Stat. 2010; 23: 1-44.
8. Stewart WF, Wood C, Reed ML, Roy J, Lipton RB,. Cumulative lifetime migraine incidence in women and men. Cephalalgia. 2008; 28: 1170-1178.
9. Tietjen GE, Conway A, Utley C, Gunning WT, Herial NA,. Migraine is associated with menorrhagia and endometriosis. Headache. 2006; 46: 422-428.
10. Bast RC, Jr, Brewer M, Zou C, et al,. Prevention and early detection of ovarian cancer: Mission impossible? Recent Results Cancer Res. 2007; 174: 91-100.
11. Speroff LD, Philip D,. "Oral Contraception." A Clinical Guide for Contraception, 4th edn. Philadelphia, PA: Lippincott Williams & Wilkins; 2005.
12. Huber JC, Bentz EK, Ott J, Tempfer CB,. Non-contraceptive benefits of oral contraceptives. Expert Opin Pharmacother. 2008; 9: 2317-2325.
13. Vessey M, Yeates D, Flynn S,. Factors affecting mortality in a large cohort study with special reference to oral contraceptive use. Contraception. 2010; 82: 221-229.
14. Oral contraceptives and stroke in young women. Associated risk factors. JAMA. 1975; 231: 718-722.
15. Lidegaard O, Kreiner S,. Contraceptives and cerebral thrombosis: A five-year national case-control study. Contraception. 2002; 65: 197-205. (Pubitemid 34258540)
16. Ischaemic stroke and combined oral contraceptives: Results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet. 1996; 348: 498-505.
17. Petitti DB, Sidney S, Bernstein A, Wolf S, Quesenberry C, Ziel HK,. Stroke in users of low-dose oral contraceptives. N Engl J Med. 1996; 335: 8-15. (Pubitemid 26230807)
18. Schwartz SM, Petitti DB, Siscovick DS, et al,. Stroke and use of low-dose oral contraceptives in young women: a pooled analysis of two US studies. Stroke. 1998; 29: 2277-2284. (Pubitemid 28511944)
19. Chan WS, Ray J, Wai EK, et al,. Risk of stroke in women exposed to low-dose oral contraceptives: A critical evaluation of the evidence. Arch Intern Med. 2004; 164: 741-747. (Pubitemid 38478696)
20. MacGregor EA,. Oestrogen and attacks of migraine with and without aura. Lancet Neurol. 2004; 3: 354-361. (Pubitemid 38648856)
21. Donaghy M, Chang CL, Poulter N,. Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age. J Neurol Neurosurg Psychiatry. 2002; 73: 747-750. (Pubitemid 35448863)
22. Kurth T, Slomke MA, Kase CS, et al,. Migraine, headache, and the risk of stroke in women: A prospective study. Neurology. 2005; 64: 1020-1026. (Pubitemid 40388455)
23. Calhoun A, Ford S, Pruitt A,. Extended-cycle use of a ring contraceptive may reduce frequency of migraine aura. In: American Headache Society Annual Scientific Meeting. Washington, DC; 2011.
24. Birtch RL, Olatunbosun OA, Pierson RA,. Ovarian follicular dynamics during conventional vs. continuous oral contraceptive use. Contraception. 2006; 73: 235-243. (Pubitemid 43202172)
25. Baerwald AR, Pierson RA,. Ovarian follicular development during the use of oral contraception: A review. J Obstet Gynaecol Can. 2004; 26: 19-24.